product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MKK7 Antibody
catalog :
4172S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation
citations: 2
Published Application/Species/DilutionReference
Ngai S, Batty S, Liao K, Mogridge J. An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity. FEBS J. 2010;277:119-27 pubmed publisher
Zapata H, Nakatsugawa M, Moffat J. Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J Virol. 2007;81:977-90 pubmed
product information
SKU :
4172S
Product-Name :
MKK7 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunoprecipitation
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
48
Host :
Rabbit
Target :
MKK7
Primary-Protein :
MKK7
Alt-Names :
Dual specificity mitogen-activated protein kinase kinase 7,JNK kinase 2,JNK-activating kinase 2,JNKK 2,JNKK2,MAP kinase kinase 7,MAP2K7,MAPK/ERK kinase 7,MAPKK 7,MAPKK7,MEK 7,MEK7,MKK7,MP2K7,PRKMK7,c-Jun N-terminal kinase kinase 2,mitogen-activated protein kinase kinase 7
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.